Search results
Meerjarenonderzoeksplan 2022-2024
Middellangetermijnverkenning zorg 2022-2025
Toelichting raming zorguitgaven voor mlt en houdbaarheid
Does managed competition constrain hospitals’ contract prices? Evidence from the Netherlands
In the Dutch health care system health insurers negotiate with hospitals about the pricing of hospital products in a managed competition framework. In this paper, we study these contract prices that became for the first time publicly available in 2016. The data show substantive price variation between hospitals for the same products, and within a hospital for the same product across insurers. →
Competition and pricing behavior in long term care markets: Evidence from the Market for Assistance in Daily Housekeeping Activities
Exploiting a rich data set on the Dutch market for assistance in daily housekeeping activities (ADHA), we find that larger providers obtain a higher price than do small providers. However, compared to other studies on market power in care markets this price difference is considered small to moderate. →
Toelichting middellangetermijn (mlt)-raming voor de Wmo / jeugd
Premium levels and demand response in health insurance: relative thinking and zero-price effects
In health care systems with a competitive health insurance market, governments or other sponsors (e.g. employers) often subsidize premiums to encourage enrolment. These subsidies are typically independent of plan choice leaving the absolute premium differences in place so as not to distort consumer choice of plan. →
Actualisatie Middellangetermijnverkenning 2018-2021
Deze CPB Notitie geeft een nadere actualisatie van de Middellangetermijnverkenning 2018-2021. De notitie beschrijft het economische en budgettaire beeld voor de periode 2018-2021 en geeft vervolgens een overzicht van de verschillen ten opzichte van de verkenning uit maart 2017. Belangrijke wijzigingen ten opzichte van de vorige verkenning vormen de hogere groei op korte termijn en het kwaliteitskader verpleeghuiszorg. →
Publication year
Authors
- Rudy Douven (8)
- Esther Mot (5)
- Paul Besseling (3)
- Rob Aalbers (3)
- Annette Zeilstra (2)
- Arno Meijer (2)
- Daniel van Vuuren (2)
- Mark Kattenberg (2)
- Pierre Koning (2)
- Remco van Eijkel (2)
- Wouter Vermeulen (2)
- Adri den Ouden (1)
- Albert van der Horst (1)
- Frits Bos (1)
- Kasper Stuut (1)
- Marcel Lever (1)
- Marcel Timmer (1)
- Mathijn Wilkens (1)
- Michiel Bijlsma (1)
- Michiel van Leuvensteijn (1)
- Patrick Koot (1)
- Paul Westra (1)
- Petra Messelink (1)
- Rocus van Opstal (1)
- Ron van der Heijden (1)
- Victoria Shestalova (1)
- Viktoria Kocsis (1)
- Wim Suyker (1)
- Wouter Elsenburg (1)
- Show all
Tags
- Health care (28)
- Macroeconomics (28)
- Public finances (18)
- Risk and regulation (10)
- Competition and regulation (8)
- General welfare (4)
- Government (2)
- Built environment (1)
- COVID-19 (1)
- Climate and Environment (1)
- Data science team (1)
- International analysis (1)
- Knowledge and Innovation (1)
- Labour (1)
- Local government (1)
- Long-term outlook (1)
- Model quality (1)
- Taxation (1)
- Welfare state (1)
- purchase power (1)
- Show all